Lorena Carmona‐Rodríguez

495 total citations
12 papers, 345 citations indexed

About

Lorena Carmona‐Rodríguez is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lorena Carmona‐Rodríguez has authored 12 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Lorena Carmona‐Rodríguez's work include Immune cells in cancer (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Lorena Carmona‐Rodríguez is often cited by papers focused on Immune cells in cancer (4 papers), Angiogenesis and VEGF in Cancer (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Lorena Carmona‐Rodríguez collaborates with scholars based in Spain, United States and Germany. Lorena Carmona‐Rodríguez's co-authors include Santos Mañes, E. Mira, Rosa Ana Lacalle, Raquel Blanco, María Jesús Fernández‐Aceñero, Melchor Álvarez‐Mon, Eduardo López‐Collazo, Gorjana Rackov, Dimitrios Balomenos and Carlos Martı́nez-A and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Frontiers in Immunology.

In The Last Decade

Lorena Carmona‐Rodríguez

12 papers receiving 341 citations

Peers

Lorena Carmona‐Rodríguez
Da Qian China
Guangyao Yu United States
Linda Tran United States
Lijie Yin China
Lijun Xu China
Da Qian China
Lorena Carmona‐Rodríguez
Citations per year, relative to Lorena Carmona‐Rodríguez Lorena Carmona‐Rodríguez (= 1×) peers Da Qian

Countries citing papers authored by Lorena Carmona‐Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Lorena Carmona‐Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Carmona‐Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Carmona‐Rodríguez more than expected).

Fields of papers citing papers by Lorena Carmona‐Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena Carmona‐Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Carmona‐Rodríguez. The network helps show where Lorena Carmona‐Rodríguez may publish in the future.

Co-authorship network of co-authors of Lorena Carmona‐Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena Carmona‐Rodríguez. A scholar is included among the top collaborators of Lorena Carmona‐Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena Carmona‐Rodríguez. Lorena Carmona‐Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Guerrero, Laura, Lorena Carmona‐Rodríguez, Sergio Ciordia, et al.. (2024). Molecular basis of progressive familial intrahepatic cholestasis 3. A proteomics study. BioFactors. 50(4). 794–809. 5 indexed citations
2.
Guerrero, Laura, Nabil Djouder, Jaime Millán, et al.. (2024). Molecular Insights of Cholestasis in MDR2 Knockout Murine Liver Organoids. Journal of Proteome Research. 23(4). 1433–1442. 2 indexed citations
3.
Carmona‐Rodríguez, Lorena, et al.. (2022). Superoxide Dismutase-3 Downregulates Laminin α5 Expression in Tumor Endothelial Cells via the Inhibition of Nuclear Factor Kappa B Signaling. Cancers. 14(5). 1226–1226. 5 indexed citations
4.
Núñez, Estefanía, Irene Orera, Lorena Carmona‐Rodríguez, et al.. (2022). Mapping the Serum Proteome of COVID-19 Patients; Guidance for Severity Assessment. Biomedicines. 10(7). 1690–1690. 10 indexed citations
5.
Carmona‐Rodríguez, Lorena, et al.. (2020). Extracellular Superoxide Dismutase, the Endothelial Basement Membrane, and the WNT Pathway: New Players in Vascular Normalization and Tumor Infiltration by T-Cells. Frontiers in Immunology. 11. 579552–579552. 16 indexed citations
6.
Carmona‐Rodríguez, Lorena, María Jesús Fernández‐Aceñero, Alicia González-Martín, et al.. (2020). SOD3 induces a HIF-2α-dependent program in endothelial cells that provides a selective signal for tumor infiltration by T cells. Journal for ImmunoTherapy of Cancer. 8(1). e000432–e000432. 36 indexed citations
7.
Soriano‐Maldonado, Alberto, Manuel Ferrer‐Márquez, Alba Hernández‐Martínez, et al.. (2020). Physical Exercise following bariatric surgery in women with Morbid obesity. Medicine. 99(12). e19427–e19427. 12 indexed citations
8.
Carmona‐Rodríguez, Lorena, et al.. (2020). SOD3 boosts T cell infiltration by normalizing the tumor endothelium and inducing laminin-α4. OncoImmunology. 9(1). 1794163–1794163. 12 indexed citations
9.
Mira, E., Lorena Carmona‐Rodríguez, Beatriz Pérez‐Villamil, et al.. (2018). SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α. Nature Communications. 9(1). 575–575. 51 indexed citations
10.
Lacalle, Rosa Ana, et al.. (2016). Chemokine Receptor Signaling and the Hallmarks of Cancer. International review of cell and molecular biology. 331. 181–244. 66 indexed citations
11.
Rackov, Gorjana, Enrique Hernández-Jiménez, Lorena Carmona‐Rodríguez, et al.. (2016). p21 mediates macrophage reprogramming through regulation of p50-p50 NF-κB and IFN-β. Journal of Clinical Investigation. 126(8). 3089–3103. 85 indexed citations
12.
Mira, E., Lorena Carmona‐Rodríguez, Manuel Tardáguila, et al.. (2013). A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors. Oncotarget. 4(12). 2288–2301. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026